Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical Co., Ltd. (SNPHY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SNPHY · as of Jun 9, 2026
Key Statistics
Explore Santen Pharmaceutical Co., Ltd. Data
snphy stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
snphy competitorsSNPHY
BVNKF
HAWPF
HAWPY
MAHLY
MEPDFStock Performance
Full HistoryAbout Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical Co., Ltd. is a global enterprise dedicated to the research, development, manufacturing, and distribution of pharmaceuticals and medical devices, with operations spanning Japan an…
what is santen pharmaceutical co., ltd. · snphy stock overview · santen pharmaceutical co., ltd. company profile · who is santen pharmaceutical co., ltd. ceo · snphy OTC · santen pharmaceutical co., ltd. headquarters · santen pharmaceutical co., ltd. business segments
About Stock Overview & Key Data
Santen Pharmaceutical Co., Ltd. (SNPHY) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Aug 31, 2011. As of the latest trading session, SNPHY stock price is $12.15, with a market capitalization of $3.9B. The stock has returned +6.95% over the past 12 months and +17.96% year-to-date.
In fiscal year 2026, Santen Pharmaceutical Co., Ltd. reported revenue of $309.2B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Santen Pharmaceutical Co., Ltd. (SNPHY) stock price is $12.15. The stock is traded on OTC under the ticker symbol SNPHY. The 52-week range is $9.22 – $12.68.